688278.SHG Xiamen Amoytop Biotech Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
45.64 CNY
Close of Nov 5, 2026
41.11 85.57
Market cap
CNY 18.6B
P/E
22.3x
P/B
5.65x
ROE
19.7%
Dividend yield
1.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688278.SHG undervalued?

Graham number
Price45.64
Graham value19.31
Premium136.4%

688278.SHG trades 136.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Xiamen Amoytop Biotech Co Ltd fundamental analysis

No fundamental analysis for Xiamen Amoytop Biotech Co Ltd yet.

Xiamen Amoytop Biotech Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Xiamen Amoytop Biotech Co Ltd

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xi…

Full company profile